Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

How Metal Ion Lewis Acidity and Steric Properties Influence the Barrier to Dioxygen Binding, Peroxo O-O Bond Cleavage, and Reactivity.

Yan Poon PC, Dedushko MA, Sun X, Yang G, Toledo S, Hayes EC, Johansen A, Piquette MC, Rees JA, Stoll S, Rybak-Akimova E, Kovacs JA.

J Am Chem Soc. 2019 Sep 13. doi: 10.1021/jacs.9b04729. [Epub ahead of print]

PMID:
31480847
2.

Porosity and pore size distribution in a sedimentary rock: Implications for the distribution of chlorinated solvents.

Shapiro AM, Evans CE, Hayes EC.

J Contam Hydrol. 2017 Aug;203:70-84. doi: 10.1016/j.jconhyd.2017.06.006. Epub 2017 Jun 28.

PMID:
28693899
3.

Sterically directed nitronate complexes of 2,6-di-tert-butyl-4-nitrophenoxide with Cu(ii) and Zn(ii) and their H-atom transfer reactivity.

Porter TR, Hayes EC, Kaminsky W, Mayer JM.

Dalton Trans. 2017 Feb 21;46(8):2551-2558. doi: 10.1039/c6dt04427a.

4.

EPR Study of UV-Irradiated Thymidine Microcrystals Supports Radical Intermediates in Spore Photoproduct Formation.

Hayes EC, Jian Y, Li L, Stoll S.

J Phys Chem B. 2016 Oct 27;120(42):10923-10931. doi: 10.1021/acs.jpcb.6b06587. Epub 2016 Oct 17.

5.

Electronic Structure of a Cu(II)-Alkoxide Complex Modeling Intermediates in Copper-Catalyzed Alcohol Oxidations.

Hayes EC, Porter TR, Barrows CJ, Kaminsky W, Mayer JM, Stoll S.

J Am Chem Soc. 2016 Mar 30;138(12):4132-45. doi: 10.1021/jacs.5b13088. Epub 2016 Mar 18.

6.

TriCalm(®) hydrogel is significantly superior to 2% diphenhydramine and 1% hydrocortisone in reducing the peak intensity, duration, and overall magnitude of cowhage-induced itch.

Papoiu AD, Chaudhry H, Hayes EC, Chan YH, Herbst KD.

Clin Cosmet Investig Dermatol. 2015 Apr 24;8:223-9. doi: 10.2147/CCID.S78809. eCollection 2015.

7.

Vibrational Stark effect spectroscopy reveals complementary electrostatic fields created by protein-protein binding at the interface of Ras and Ral.

Walker DM, Hayes EC, Webb LJ.

Phys Chem Chem Phys. 2013 Aug 7;15(29):12241-52. doi: 10.1039/c3cp51284c. Epub 2013 Jun 17.

PMID:
23771025
8.

Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERalpha.

Dykstra KD, Guo L, Birzin ET, Chan W, Yang YT, Hayes EC, DaSilva CA, Pai LY, Mosley RT, Kraker B, Fitzgerald PM, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2007 Apr 15;17(8):2322-8. Epub 2007 Jan 25.

PMID:
17289385
9.

Effect of glycodelin on the production of vascular endothelial growth factor in cumulus cells.

Hayes EC, Dominguez CE, Voelkel S, Song M, Shanti AS, Murphy AA.

Fertil Steril. 2006 May;85(5):1553-6.

PMID:
16647384
10.

The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.

Wilkening RR, Ratcliffe RW, Tynebor EC, Wildonger KJ, Fried AK, Hammond ML, Mosley RT, Fitzgerald PM, Sharma N, McKeever BM, Nilsson S, Carlquist M, Thorsell A, Locco L, Katz R, Frisch K, Birzin ET, Wilkinson HA, Mitra S, Cai S, Hayes EC, Schaeffer JM, Rohrer SP.

Bioorg Med Chem Lett. 2006 Jul 1;16(13):3489-94. Epub 2006 May 2.

PMID:
16632357
11.

Estrogen receptor ligands. Part 14: application of novel antagonist side chains to existing platforms.

Blizzard TA, Morgan JD 2nd, Chan W, Birzin ET, Pai LY, Hayes EC, DaSilva CA, Mosley RT, Yang YT, Rohrer SP, Dininno F, Hammond ML.

Bioorg Med Chem Lett. 2005 Dec 1;15(23):5124-8. Epub 2005 Oct 3.

PMID:
16203138
12.

Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.

Blizzard TA, DiNinno F, Chen HY, Kim S, Wu JY, Chan W, Birzin ET, Yang YT, Pai LY, Hayes EC, DaSilva CA, Rohrer SP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2005 Sep 1;15(17):3912-6.

PMID:
15993065
13.

Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs.

Tan Q, Blizzard TA, Morgan JD 2nd, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC, DaSilva CA, Warrier S, Yudkovitz J, Wilkinson HA, Sharma N, Fitzgerald PM, Li S, Colwell L, Fisher JE, Adamski S, Reszka AA, Kimmel D, DiNinno F, Rohrer SP, Freedman LP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2005 Mar 15;15(6):1675-81.

PMID:
15745820
14.

Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans.

Liu J, Birzin ET, Chan W, Yang YT, Pai LY, Dasilva C, Hayes EC, Mosley RT, Dininno F, Rohrer SP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2005 Feb 1;15(3):715-8.

PMID:
15664843
15.

Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers.

Blizzard TA, Dininno F, Morgan JD 2nd, Chen HY, Wu JY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Fitzgerald PM, Sharma N, Li Y, Zhang Z, Hayes EC, Dasilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2005 Jan 3;15(1):107-13.

PMID:
15582421
16.

Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains.

Blizzard TA, DiNinno F, Morgan JD 2nd, Wu JY, Chen HY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2004 Aug 2;14(15):3865-8.

PMID:
15225686
17.

Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains.

Blizzard TA, DiNinno F, Morgan JD 2nd, Chen HY, Wu JY, Gude C, Kim S, Chan W, Birzin ET, Tien Yang Y, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2004 Aug 2;14(15):3861-4.

PMID:
15225685
18.

Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.

Tan Q, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC, DaSilva CA, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2004 Jul 16;14(14):3753-5.

PMID:
15203156
19.

Estrogen receptor ligands. Part 5: The SAR of dihydrobenzoxathiins containing modified basic side chains.

Tan Q, Birzin ET, Chan W, Tien Yang Y, Pai LY, Hayes EC, DaSilva CA, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.

Bioorg Med Chem Lett. 2004 Jul 16;14(14):3747-51.

PMID:
15203155
20.

Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-alpha and -beta in the breast cancer cell line MCF-7.

Peekhaus NT, Chang T, Hayes EC, Wilkinson HA, Mitra SW, Schaeffer JM, Rohrer SP.

J Mol Endocrinol. 2004 Jun;32(3):987-95.

PMID:
15171727
21.

COX-2 inhibitors and their role in gynecology.

Hayes EC, Rock JA.

Obstet Gynecol Surv. 2002 Nov;57(11):768-80. Review.

PMID:
12447099
22.

Treatment of vaginal agglutination associated with chronic graft-versus-host disease.

Hayes EC, Rock JA.

Fertil Steril. 2002 Nov;78(5):1125-6.

PMID:
12414005
23.

A comparison of medical induction and dilation and evacuation for second-trimester abortion.

Autry AM, Hayes EC, Jacobson GF, Kirby RS.

Am J Obstet Gynecol. 2002 Aug;187(2):393-7.

PMID:
12193931
24.

Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells.

Parmar RM, Chan WW, Dashkevicz M, Hayes EC, Rohrer SP, Smith RG, Schaeffer JM, Blake AD.

Biochem Biophys Res Commun. 1999 Sep 24;263(2):276-80.

PMID:
10491284
25.

A standard of care for radial artery grafting.

Hayes EC, L'Ecuyer KM.

Am J Crit Care. 1998 Nov;7(6):429-35. Review.

PMID:
9805116
26.

Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.

Rohrer SP, Birzin ET, Mosley RT, Berk SC, Hutchins SM, Shen DM, Xiong Y, Hayes EC, Parmar RM, Foor F, Mitra SW, Degrado SJ, Shu M, Klopp JM, Cai SJ, Blake A, Chan WW, Pasternak A, Yang L, Patchett AA, Smith RG, Chapman KT, Schaeffer JM.

Science. 1998 Oct 23;282(5389):737-40. Erratum in: Science 1998 Nov 27;282(5394):1646.

27.

Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.

Yang L, Berk SC, Rohrer SP, Mosley RT, Guo L, Underwood DJ, Arison BH, Birzin ET, Hayes EC, Mitra SW, Parmar RM, Cheng K, Wu TJ, Butler BS, Foor F, Pasternak A, Pan Y, Silva M, Freidinger RM, Smith RG, Chapman K, Schaeffer JM, Patchett AA.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10836-41.

28.

Identification of neuron-specific ivermectin binding sites in Drosophila melanogaster and Schistocerca americana.

Rohrer SP, Birzin ET, Costa SD, Arena JP, Hayes EC, Schaeffer JM.

Insect Biochem Mol Biol. 1995 Jan;25(1):11-7.

PMID:
7711743
29.
30.

Affinity probes for the avermectin binding proteins.

Meinke PT, Rohrer SP, Hayes EC, Schaeffer JM, Fisher MH, Mrozik H.

J Med Chem. 1992 Oct 16;35(21):3879-84.

PMID:
1433197
31.

Photoaffinity labeling of avermectin binding sites from Caenorhabditis elegans and Drosophila melanogaster.

Rohrer SP, Meinke PT, Hayes EC, Mrozik H, Schaeffer JM.

Proc Natl Acad Sci U S A. 1992 May 1;89(9):4168-72.

32.

Preparation of antibodies directed against leukotrienes.

Hayes EC.

Methods Enzymol. 1990;187:116-24. No abstract available.

PMID:
2122183
33.

Leukotrienes LTB4 and LTC4 in thermally injured patients' plasma and burn blister fluid.

Dobke MK, Hayes EC, Baxter CR.

J Burn Care Rehabil. 1987 May-Jun;8(3):189-91.

PMID:
3038921
34.

Development of enzyme-linked immunosorbent assays for measurement of leukotrienes and prostaglandins.

Miller DK, Sadowski S, DeSousa D, Maycock AL, Lombardo DL, Young RN, Hayes EC.

J Immunol Methods. 1985 Aug 2;81(2):169-85.

PMID:
2991387
35.

The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells.

Peters SP, MacGlashan DW Jr, Schleimer RP, Hayes EC, Adkinson NF Jr, Lichtenstein LM.

Am Rev Respir Dis. 1985 Aug;132(2):367-73.

PMID:
3927806
36.

Thyrotropin-releasing hormone blocks the hypotensive effects of platelet-activating factor in the unanesthetized guinea pig.

Feuerstein G, Lux WE Jr, Ezra D, Hayes EC, Snyder F, Faden AI.

J Cardiovasc Pharmacol. 1985 Mar-Apr;7(2):335-40.

PMID:
2581089
37.
38.

Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.

Creticos PS, Peters SP, Adkinson NF Jr, Naclerio RM, Hayes EC, Norman PS, Lichtenstein LM.

N Engl J Med. 1984 Jun 21;310(25):1626-30.

PMID:
6328300
39.

Arachidonic acid metabolism in purified human lung mast cells.

Peters SP, MacGlashan DW Jr, Schulman ES, Schleimer RP, Hayes EC, Rokach J, Adkinson NF Jr, Lichtenstein LM.

J Immunol. 1984 Apr;132(4):1972-9.

PMID:
6199420
40.

The development of sensitive and specific radioimmunoassays for leukotrienes.

Rokach J, Hayes EC, Girard Y, Lombardo DL, Maycock AL, Rosenthal AS, Young RN, Zamboni R, Zweerink HJ.

Prostaglandins Leukot Med. 1984 Jan;13(1):21-5.

PMID:
6324239
41.

Separation of major prostaglandins, leukotrienes, and monoHETEs by high performance liquid chromatography.

Peters SP, Schulman ES, Liu MC, Hayes EC, Lichtenstein LM.

J Immunol Methods. 1983 Nov 25;64(3):335-43.

PMID:
6321597
42.

Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay.

Hayes EC, Lombardo DL, Girard Y, Maycock AL, Rokach J, Rosenthal AS, Young RN, Egan RW, Zweerink HJ.

J Immunol. 1983 Jul;131(1):429-33.

PMID:
6190920
43.

Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.

Schleimer RP, Schulman ES, MacGlashan DW Jr, Peters SP, Hayes EC, Adams GK 3rd, Lichtenstein LM, Adkinson NF Jr.

J Clin Invest. 1983 Jun;71(6):1830-5.

44.

Cells infected with a cell-associated subacute sclerosing panencephalitis virus do not express M protein.

Machamer CE, Hayes EC, Zweerink HJ.

Virology. 1981 Jan 30;108(2):515-20. No abstract available.

PMID:
7467128
45.

Protein sigma 1 is the reovirus cell attachment protein.

Lee PW, Hayes EC, Joklik WK.

Virology. 1981 Jan 15;108(1):156-63. No abstract available.

PMID:
7269235
46.

The interaction of a series of hybridoma IgGs with reovirus particles. Demonstration that the core protein lambda 2 is exposed on the particle surface.

Hayes EC, Lee PW, Miller SE, Joklik WK.

Virology. 1981 Jan 15;108(1):147-55. No abstract available.

PMID:
7269234
47.

Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines.

Lee PW, Hayes EC, Joklik WK.

Virology. 1981 Jan 15;108(1):134-46. No abstract available.

PMID:
7269233
48.

Antibodies against the measles matrix polypeptide after clinical infection and vaccination.

Machamer CE, Hayes EC, Gollobin SD, Westfall LK, Zweerink HJ.

Infect Immun. 1980 Mar;27(3):817-25.

49.

Measles-specific antibodies in sera and cerebrospinal fluids of patients with multiple sclerosis.

Hayes EC, Gollobin SD, Machamer CE, Westfall LK, Zweerink HJ.

Infect Immun. 1980 Mar;27(3):1033-7.

50.

Supplemental Content

Loading ...
Support Center